TREK-1 inhibition promotes synaptic plasticity in the prelimbic cortex

Area of Science:

• Neuroscience
• Molecular Biology
• Psychiatry

Background:

• Synaptic plasticity in the prefrontal cortex (PFC) is crucial for development.
• Early life stress (ELS) impairs PFC maturation and synaptic plasticity, contributing to mood disorders.
• The TREK-1 potassium channel is implicated in synaptic modifications relevant to mood disorders.

Purpose of the Study:

• To investigate the role of TREK-1 in synaptic plasticity within the prelimbic division (PL) of the PFC.
• To examine the effects of TREK-1 blockade on synaptic plasticity in both non-stressed and ELS animal models.
• To explore potential antidepressant mechanisms related to TREK-1 modulation.

Main Methods:

• Utilized brain slice electrophysiology to assess synaptic plasticity in the PL circuitry.
• Evaluated the impact of pharmacological TREK-1 blockade.
• Compared effects in naive animals versus those subjected to ELS.

Main Results:

• In non-stressed animals, TREK-1 activity is necessary for 5-HT_1A receptor-mediated synaptic response reduction.
• TREK-1 blockade, combined with 5-HT_1A receptor stimulation, promotes long-term depression (LTD) in naive rats.
• In ELS animals, TREK-1 blockade decreases synaptic transmission and enhances LTD.
• TREK-1 inhibition stimulates PL synaptic plasticity, with a more pronounced effect in ELS animals.

Conclusions:

• TREK-1 activity is a key regulator of synaptic plasticity in the developing PFC.
• Pharmacological inhibition of TREK-1 enhances synaptic plasticity, particularly LTD, in the PL.
• These findings suggest TREK-1 as a potential therapeutic target for mood disorders, especially those linked to early life stress.